17597478

Source:http://linkedlifedata.com/resource/pubmed/id/17597478

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002199, umls-concept:C0030705, umls-concept:C0032463, umls-concept:C0040028, umls-concept:C0442027, umls-concept:C0596545
pubmed:issue	9
pubmed:dateCreated	2007-8-13
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7610369
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Immunologic Factors, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/JAK2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Janus Kinase 2
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0361-8609
pubmed:author	pubmed-author:Quintás-CardamaAlfonsoA, pubmed-author:VerstovsekSrdanS
pubmed:issnType	Print
pubmed:volume	82
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	859
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:17597478-Administration, Oral, pubmed-meshheading:17597478-Adult, pubmed-meshheading:17597478-Aged, pubmed-meshheading:17597478-Chromosome Aberrations, pubmed-meshheading:17597478-Dose-Response Relationship, Drug, pubmed-meshheading:17597478-Drug Administration Schedule, pubmed-meshheading:17597478-Drug Tolerance, pubmed-meshheading:17597478-Headache, pubmed-meshheading:17597478-Humans, pubmed-meshheading:17597478-Immunologic Factors, pubmed-meshheading:17597478-Interferon-alpha, pubmed-meshheading:17597478-Janus Kinase 2, pubmed-meshheading:17597478-Middle Aged, pubmed-meshheading:17597478-Mutation, pubmed-meshheading:17597478-Paresthesia, pubmed-meshheading:17597478-Pilot Projects, pubmed-meshheading:17597478-Polycythemia Vera, pubmed-meshheading:17597478-Thrombocytosis, pubmed-meshheading:17597478-Time Factors
pubmed:year	2007
pubmed:articleTitle	Experience with oral interferon-alpha in patients with essential thrombocythemia and polycythemia vera.
pubmed:publicationType	Letter, Clinical Trial